menu toggle
Martin Luther King Jr. Day
Cencora's distribution centers will be open and operating as normal on Monday, January 19. Customer Service and Customer Systems Support teams will also remain available to take your orders and assist with your requests, however our business offices will be closed. While we are accepting and processing orders, if your order requires additional attention from a business department that is unavailable, it will be processed the next business day. For more information, review the holiday schedule dashboard to plan your orders accordingly.
View holiday schedule dashboard

Outlook Therapeutics® and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD

ISELIN, N.J. and CONSHOHOCKEN, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, and AmerisourceBergen (NYSE: ABC), a global healthcare company and leader in specialty pharmaceutical distribution and services, announced today that they have entered into a strategic relationship in preparation for the anticipated commercial launch in the United States of ONS-5010 / LYTENAVA™ (bevacizumab-vikg), if approved by the U.S. Food and Drug Administration (FDA).

More in the Media

The DSCSA Clock Is Ticking

September 02, 2024

How Heat Waves Threaten the Pharma Cold Chain

August 19, 2024

Addressing Access and Affordability Issues With Collaboration at Asembia 2024

May 06, 2024

Understanding State Regulations and Advocating for Medically Integrated Dispensing

May 03, 2024